Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates. Le Hingrat Q, Collin G, Bachelard A, Ghosn J, et al. AIDS 2022 Mar 8. pii: 00002030-990000000-00001.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Le Hingrat Q, Collin G, Bachelard A, Ghosn J, et al. Ibalizumab shows in vitro activity against group A and group B HIV-2 clinical isolates. AIDS 2022 Mar 8. pii: 00002030-990000000-00001.
PMID: 35262531